Mark Ahn carries a long history in the prescription drug industry, doing work in several spots to better the day-to-day lives of men and women. He started his career at Chamindade University, where Mark Ahn acquired a B.A. and a M.B.A. in advance of moving on to Victoria University the place where Mr. Ahn received an M.A. To help support his chosen vocation, Mr. Ahn invested time at Essex University as a graduate fellow in Economics right before relocating to the University of South Australia where Mark Ahn won the name of Mark J. Ahn Ph.D. Upon departing his classes, Mr. Ahn continues to be busy. Not merely has he authored more than 50 peer reviewed publications and journal articles, Ahn has furthermore retained jobs of expertise in many different leading firms. He has done work for key corporations such as Bristol-Myers Squibb and Amgen before being named Genentech, Inc.’s Vice President, Hematology and also corporate officer. On leaving Genentech, Ahn helped found Hana Biosciences where he happily served as President and Chief Executive Officer. Then he relocated to Pukana Partners, Ltd. and this is where he worked as a Principal. This business provides strategic advice to companies within the life science field. Mark Ahn’s most recent work was with Galena, and Ahn has also functioned to speak about his own knowledge with other people, in the role of Victoria University’s Professor and Chair, Science and Technology and Williamette University Atkinson Graduate School of Management’s associate professor of Global Management. It is no wonder countless think of Mr. Ahn a frontrunner within his niche.